The haemoglobin glycation index is an independent risk factor for microvascular complications in UKPDS patients with newly diagnosed type 2 diabetes

被引：0
|
作者：
Kim, JI
Stevens, RJ
Holman, RR
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A244 / A245
页数：2
相关论文
共 50 条
  • [1] Prevalence of microvascular complications in newly diagnosed patients with Type 2 diabetes
    Ali, Alia
    Iqbal, Farrukh
    Taj, Azeem
    Iqbal, Zafar
    Amin, Muhammad Joher
    Iqbal, Qasim Zafar
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2013, 29 (04) : 899 - 902
  • [2] Limited benefit of haemoglobin glycation index as risk factor for cardiovascular disease in type 2 diabetes patients
    Ostergaard, H. B.
    Mandrup-Poulsen, T.
    Berkelmans, G. F. N.
    van der Graaf, Y.
    Visseren, F. L. J.
    Westerink, J.
    van Petersen, R.
    Dinther, B. G. F.
    Algra, A.
    Grobbee, D. E.
    Rutten, G. Eh. M.
    de Borst, G. J.
    Kappelle, L. J.
    Leiner, T.
    Nathoe, H. M.
    [J]. DIABETES & METABOLISM, 2019, 45 (03) : 254 - 260
  • [3] The hemoglobin glycation index is not an independent predictor of the risk of microvascular complications in the diabetes control and complications trial
    Lachin, John M.
    Genuth, Saul
    Nathan, David M.
    Rutledge, Brandy N.
    [J]. DIABETES, 2007, 56 (07) : 1913 - 1921
  • [4] The glycation index is not an independent risk factor for microvascular complications in the DCCT when adjusted for HbAlc
    Lachin, JM
    Genuth, S
    Nathan, DM
    [J]. DIABETOLOGIA, 2005, 48 : A419 - A419
  • [5] FPG and HbA1c are independent risk factors for microvascular but not macrovascular complications in newly diagnosed type 2 diabetes
    Kim, JI
    Stevens, RJ
    Holman, RR
    [J]. DIABETOLOGIA, 2005, 48 : A33 - A33
  • [6] Prevalence of Microvascular Complications in Newly Diagnosed Type-2 Diabetes Mellitus
    Wani, Fayaz Ahmad
    Koul, Rakesh K.
    Raina, Akhtar A.
    Nazir, Arjumand
    Maqbool, Muzaffar
    Bhat, M. Hyat
    Shah, Parvaiz A.
    [J]. INTERNATIONAL JOURNAL OF SCIENTIFIC STUDY, 2016, 3 (10) : 102 - 105
  • [7] Nonalcoholic Fatty Liver Disease Is an Independent Risk Factor for Macrovascular and Microvascular Complications in Patients with Type 2 Diabetes
    Zhang, Lei
    Wang, Na
    Wang, Jun
    Yin, Xiaoyan
    Yang, Yuxiu
    Gao, Weiguo
    Dong, Yanhu
    [J]. DIABETES, 2019, 68
  • [8] The haemoglobin glycation index and risk for diabetes-related complications in the ADVANCE trial
    van Steen, S. C. J.
    Woodward, M.
    Chalmers, J.
    Li, Q.
    Marre, M.
    Cooper, M. E.
    Hamet, P.
    Mancia, G.
    Colagiuri, S.
    Williams, B.
    Grobbee, D. E.
    DeVries, J. H.
    [J]. DIABETOLOGIA, 2017, 60 : S522 - S523
  • [9] Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
    Stearne, MR
    Palmer, SL
    Hammersley, MS
    Franklin, SL
    Spivey, RS
    Levy, JC
    Tidy, CR
    Bell, NJ
    Steemson, J
    Barrow, BA
    Coster, R
    Waring, K
    Nolan, L
    Truscott, E
    Walravens, N
    Cook, BL
    Lampard, H
    Merle, C
    Parker, P
    McVittie, J
    Draisey, I
    Murchison, LE
    Brunt, AHE
    Williams, MJ
    Pearson, DW
    Petrie, XMP
    Lean, MEJ
    Walmsley, D
    Lyall, F
    Christie, E
    Church, J
    Thomson, E
    Farrow, A
    Stowers, JM
    Stowers, M
    McHardy, K
    Patterson, N
    Wright, AD
    Levi, NA
    Shearer, AGI
    Thompson, RJW
    Taylor, G
    Rayton, S
    Bradbury, M
    Glover, A
    Smyth-Osbourne, A
    Parkes, C
    Graham, J
    England, P
    Gyde, S
    [J]. BRITISH MEDICAL JOURNAL, 1998, 317 (7160): : 713 - 720
  • [10] General practitioners focus more on microvascular complications in patients with newly diagnosed type 2 diabetes than risk factors for cardiovascular disease
    Fhärm, E
    Svensson, M
    Rolandsson, O
    [J]. DIABETOLOGIA, 2005, 48 : A61 - A62
12345